Brief: Infinity Pharmaceuticals - Sees 2020 Net Loss Between $40 Mln To $50 Mln

Infinity Pharmaceuticals

13/01/2020 13:14

Jan 13 (Reuters) - Infinity Pharmaceuticals Inc  INFI.O :
    * INFINITY PHARMACEUTICALS - SEES 2020 NET LOSS BETWEEN $40
MILLION TO $50 MILLION
    * INFINITY PHARMACEUTICALS PROVIDES 2020 GOALS AND FINANCIAL
GUIDANCE
    * INFINITY PHARMACEUTICALS - ADDITIONAL MARIO-1 DATA
EXPECTED IN
2020
    * INFINITY PHARMACEUTICALS - MARIO-3 PHASE 2 STUDY IN TNBC &
RCC
ENROLLMENT COMPLETION & INITIAL DATA EXPECTED IN 2020
    * INFINITY PHARMACEUTICALS INC - SEES 2020 YEAR-END CASH $15
MILLION TO $25 MILLION
    * INFINITY PHARMACEUTICALS - NON-DILUTIVE FINANCING EXTENDS
CASH
RUNWAY INTO 2H 2021,FULLY FUNDS ONGOING IPI-549 CLINICAL TRIALS
THROUGH KEY DATA READOUTS
    * INFINITY PHARMACEUTICALS - OVER $60 MILLION CASH ON HAND
TO FUND
ALL CURRENT IPI-549 TRIALS TO KEY DATA READOUTS THROUGHOUT 2020
AND INTO MID-2021

Source text for Eikon:  ID:nBw89sBw2a 
Further company coverage:  INFI.O 

 ((Briefs@thomsonreuters.com;))